首页> 外文期刊>Lupus >Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus
【24h】

Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus

机译:人脐部间充质干细胞对系统性红斑狼疮患者T淋巴细胞炎症因子和miR-181a的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives The present study aimed to explore the effect of umbilical cord mesenchymal stem cells (UC-MSCs) on the modulation of T lymphocytes from system lupus erythematosus (SLE) patients and the possible mechanism. Methods A total of 24 hospitalized SLE patients and 28 healthy individuals were enrolled. T lymphocytes were sorted using Miltenyi magnetic beads. After the addition of recombinant human interleukin (IL)-2 and CD3CD28 T-cell activator, cells were loaded onto six-well plates pre-inoculated or not with UC-MSCs for 1 week of culture. The supernatants were collected for testing inflammatory factors by enzyme-linked immunosorbent assay. Meanwhile, T lymphocytes were collected to assess the expression levels of genes, proteins in relation to SLE and miR-181a by polymerase chain reaction and Western blot. Results Compared with T lymphocytes cultured alone, interferon-γ, IL-4, IL-6 and IL-10 levels were significantly decreased in T lymphocytes from SLE patients co-cultured with UC-MSCs. In addition, the gene and protein expression levels of TNF alpha, osteopontin and nuclear factor-kappa B in T lymphocytes were significantly decreased, while miR-181a expression was markedly elevated ( p ?
机译:目的本研究旨在探讨脐带间充质干细胞(UC-MSCs)对来自系统狼疮性红斑(SLE)患者的T淋巴细胞调节的影响及可能的机制。方法共有24名住院患者和28例健康个体。使用Miltenyi磁珠对T淋巴细胞进行分类。在加入重组人白细胞介素(IL)-2和CD3CD28 T细胞活化剂后,将细胞加载到预接种的六孔板上,或者没有用UC-MSCs进行1周培养。收集上清液以通过酶联免疫吸附测定检测炎症因子。同时,收集T淋巴细胞以评估基因的表达水平,通过聚合酶链反应和Western印迹与SLE和miR-181a相关的基因。结果与单独培养的T淋巴细胞相比,SLE患者与UC-MSC共同培养的TS淋巴细胞中的干扰素-γ,IL-4,IL-6和IL-10水平显着降低。此外,TNFα的基因和蛋白表达水平在T淋巴细胞中的TNFα,骨桥蛋白和核因子-Kappa B的基因显着降低,而MIR-181A表达明显升高(P≤0.05或0.008)。结论UC-MSCs在SLE患者的T淋巴细胞上表现出某些免疫调节和抑制作用,这可能是对疾病的有益疗效。 UC-MSCs可以上调miR-181a和下调炎症相关的基因表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号